Please login to the form below

Not currently logged in

Roche files patent lawsuit against Teva for osteoporosis drug

Roche files a lawsuit against generic manufacturer Teva over an alleged patent violation on its osteoporosis treatment, Boniva

Swiss pharmaceutical company Roche has filed a lawsuit against Israel-headquartered generic manufacturer Teva over an alleged patent violation on its osteoporosis treatment Boniva (ibandronate).

A Roche spokesperson said the lawsuit was instituted to prevent Teva from marketing a generic version of Boniva 150 mg tablets. The basic patent runs until 2012, with further patents protecting the drug until 2023.

Boniva recorded sales of CHF 374m (USD 315.7m) in H1 FY07, according to Roche.

30th September 2008


Featured jobs

Subscribe to our email news alerts


Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...